Qualigen Therapeutics, Inc. (QLGN)

Qualigen Therapeutics Revenue

Qualigen Therapeutics had revenue of $1.63M in the twelve months ending March 31, 2024, with 13.74% growth year-over-year.

• Revenue (ttm): $1.63M
• Revenue Growth: +13.74%
• P/S Ratio: 2.05
• Revenue / Employee: $406,758
• Employees: 4
• Market Cap: 3.33M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	0	-	-
Dec 31, 2022	0	-	-
Dec 31, 2021	5.65M	95.76K	1.72%
Mar 31, 2020	5.56M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.